The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening
about
Foetal and neonatal alloimmune thrombocytopaeniaNeonatal thrombocytopenia: causes and managementFetal/Neonatal Alloimmune Thrombocytopenia: Pathogenesis, Diagnostics and PreventionFetal intracranial haemorrhages caused by fetal and neonatal alloimmune thrombocytopenia: an observational cohort study of 43 cases from an international multicentre registryManagement of severe alloimmune thrombocytopenia in the newborn.Neonatal alloimmune thrombocytopenia in the Irish population: a discrepancy between observed and expected cases.Effect of maternal anti-HPA-1a antibodies and polyclonal IVIG on the activation status of vascular endothelial cells.Maternal alloimmunization against the rare platelet-specific antigen HPA-9b (Max a) is an important cause of neonatal alloimmune thrombocytopeniaReactivity of T cells from women with antibodies to the human platelet antigen (HPA)-1a to peptides encompassing the HPA-1 polymorphism.A novel murine model of fetal and neonatal alloimmune thrombocytopenia: response to intravenous IgG therapy.Neonatal alloimmune thrombocytopenia associated with maternal-fetal incompatibility for blood group B.Developing recombinant HPA-1a-specific antibodies with abrogated Fcgamma receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia.Blockade of maternal anti-HPA-1a-mediated platelet clearance by an HPA-1a epitope-specific F(ab') in an in vivo mouse model of alloimmune thrombocytopenia.Congenital amegakaryocytic thrombocytopenia and thrombocytopenia with absent radii.New low-frequency platelet glycoprotein polymorphisms associated with neonatal alloimmune thrombocytopenia.Are maternal antiplatelet antibodies a prothrombotic condition leading to miscarriage?The maternal immune response to fetal platelet GPIbα causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies.New platelet glycoprotein polymorphisms causing maternal immunization and neonatal alloimmune thrombocytopeniaThe development of severe neonatal alloimmune thrombocytopenia due to anti-HPA-1a antibodies is correlated to maternal ABO genotypes.Prevalence and clinical significance of low-avidity HPA-1a antibodies in women exposed to HPA-1a during pregnancy.Crosstalk between Platelets and the Immune System: Old Systems with New DiscoveriesNeonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management.Inhibition of HPA-1a alloantibody-mediated platelet destruction by a deglycosylated anti-HPA-1a monoclonal antibody in mice: toward targeted treatment of fetal-alloimmune thrombocytopenia.Recombinant HPA-1a antibody therapy for treatment of fetomaternal alloimmune thrombocytopenia: proof of principle in human volunteersNeonatal outcome in alloimmune thrombocytopenia after maternal treatment with intravenous immunoglobulin.CRISPR/Cas9-mediated conversion of human platelet alloantigen allotypesAnti-Human Platelet Antigen-1a Immunoglobulin G Preparation Intended to Prevent Fetal and Neonatal Alloimmune ThrombocytopeniaT cell responses to human platelet antigen-1a involve a unique form of indirect allorecognition.Platelets and platelet alloantigens: Lessons from human patients and animal models of fetal and neonatal alloimmune thrombocytopeniaAnti-human platelet antigen (HPA)-1a antibodies may affect trophoblast functions crucial for placental development: a laboratory study using an in vitro model.Current perspectives on fetal and neonatal alloimmune thrombocytopenia - increasing clinical concerns and new treatment opportunities.Does Rh immune globulin suppress HLA sensitization in pregnancy?Neonatal alloimmune thrombocytopenia caused by anti-HPA antibodies in pregnant Chinese women: a study protocol for a multicentre, prospective cohort trial.Fetal exposure to maternal human platelet antigen-1a does not induce tolerance. An analytical observational studyLow-affinity FcγR interactions can decide the fate of novel human IgG-sensitised red blood cells and platelets.A variable number of tandem repeats polymorphism influences the transcriptional activity of the neonatal Fc receptor alpha-chain promoter.The prevalence of antibodies against the HLA-DRB3 protein in kidney transplantation and the correlation with HLA expression
P2860
Q21203031-1F0D9A0B-660C-4851-B24F-9F10CAEC128AQ24673677-775B8651-54B0-49A8-A9ED-3BD674A12F04Q26777281-47C73E34-1A6C-48D1-9FE8-BF93FBA332F1Q28287717-BF752354-0EFC-442A-B9B1-9E6F7D8F8891Q33332320-AF973364-A283-4F0A-AF99-59E11CDB370DQ33341730-8FBB51E3-0B77-4869-B3A2-2D4CC23D23A6Q33361251-E5F1CA6B-DB21-412A-B419-AA8C846538CDQ33368179-2BABB566-C170-4853-B09C-BBFCB2BFE201Q33368580-827506E6-84B3-4AE4-AA78-25B42C798914Q33369379-4E7089C6-C3DC-4BF0-A89F-9E28D8D8CE98Q33377497-E6EF9886-13A1-4BD9-B26D-2EEDAC361F74Q33380492-AC52B355-2114-4460-B05D-AA0D611D6661Q33381967-ECCB4280-CC52-4FCF-B1BF-54F6F58F1192Q33383921-DA463825-613A-4698-A650-1E3026E61158Q33386590-7EBB4A09-255F-4C54-891E-6A99E0E99F24Q33397766-E8EFC99F-69A7-47EC-825C-977BE5626CD6Q33397768-4584F547-B7B5-4627-8ECA-777F79CE1F39Q33398132-7013D6F7-9A6B-441E-BD81-7EB2CA815C56Q33398407-FDE348C1-9D3F-4060-8352-A9D153DCB63DQ33403500-F72466F2-C1B2-4732-BD6F-6909952DC7EAQ33403517-0E4C91A8-209C-4661-8632-D75A69E37D05Q33405694-E82B2BA7-B58D-42EC-906D-02D0FA95AFF6Q33407495-8CEBDDB8-8377-46DF-A507-08215E68713FQ33407552-4E2AB567-03D9-43B0-83DF-6A08B7AE2F7CQ33416091-078CBAD5-5F31-4E31-A919-A49DE54A8DB0Q33428137-6A0FCC3C-D667-4395-9CC5-A2E7B6A25856Q33435351-2B74CDD7-A7BE-45BB-BD01-924190C9A859Q33435753-932C6A61-AEF8-4383-A3C2-B79A1D58B728Q33440427-813CA7BA-A3C7-4A15-B43A-23BDDCE6A07AQ33441187-4C84BC55-A0D3-4308-B330-8C4F2343E0FEQ33441520-7D8D29F3-8D32-4093-90BF-DE4964FAEAEEQ36721784-7ED58F06-44F1-41AF-985F-588B2E9604B1Q38599473-415FD476-0D79-4753-80C0-B19FDBE1A4E3Q41512544-EC30F2BC-7497-48C7-9DBB-D01D727A673CQ41960767-ACD5B818-DBA9-4C87-A9C6-5303EBE9AE6DQ54594885-1B30100B-A88D-49BC-A54A-FDB035AB498CQ58760140-1E080657-54CC-4336-BDB1-C1E82D1124D4
P2860
The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
The natural history of fetomat ...... ermined by antenatal screening
@ast
The natural history of fetomat ...... ermined by antenatal screening
@en
The natural history of fetomat ...... ermined by antenatal screening
@nl
type
label
The natural history of fetomat ...... ermined by antenatal screening
@ast
The natural history of fetomat ...... ermined by antenatal screening
@en
The natural history of fetomat ...... ermined by antenatal screening
@nl
prefLabel
The natural history of fetomat ...... ermined by antenatal screening
@ast
The natural history of fetomat ...... ermined by antenatal screening
@en
The natural history of fetomat ...... ermined by antenatal screening
@nl
P2093
P3181
P1433
P1476
The natural history of fetomat ...... ermined by antenatal screening
@en
P2093
C R Palmer
L M Williamson
R Hadfield
W H Ouwehand
P304
P3181
P356
10.1016/S0887-7963(99)80009-1
P407
P577
1998-10-01T00:00:00Z